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Abstract
Background
Strongyloides stercoralis infection, a neglected tropical disease, is widely distributed.
Autochthonous cases have been described in Spain, probably infected long time ago. In
recent years the number of diagnosed cases has increased due to the growing number of
immigrants, travelers and refugees, but endemically acquired cases in Spain remains
undetermined.
Methodology
We systematically searched the literature for references on endemic strongyloidiasis cases
in Spain. The articles were required to describe Strongyloides stercoralis infection in at least
one Spanish-born person without a history of travel to endemic areas and be published
before 31st May 2018. Epidemiological data from patients was collected and described indi-
vidually as well as risk factors to acquisition of the infection, diagnostic technique that lead
to the diagnosis, presence of eosinophilia and clinical symptoms at diagnosis.
Findings
Thirty-six studies were included, describing a total of 1083 patients with an average age of
68.3 years diagnosed with endemic strongyloidiasis in Spain. The vast majority of the cases
were described in the province of Valencia (n = 1049). Two hundred and eight of the 251
(82.9%) patients in whom gender was reported were male, and most of them had current or
past dedication to agriculture. Seventy percent had some kind of comorbidity. A decreasing
trend in the diagnosed cases per year is observed from the end of last decade. However,
there are still nefigw diagnoses of autochthonous cases of strongyloidiasis in Spain every
year.
Conclusions
With the data provided by this review it is likely that in Spain strongyloidiasis might have
been underestimated. It is highly probable that the infection remains undiagnosed in many
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cases due to low clinical suspicion among Spanish population without recent travel history
in which the contagion probably took place decades ago.
Author summary
S. stercoralis is a soil transmitted helminth that is common in many subtropical and tropi-
cal countries, but is also found in other regions of the world. In this study we reviewed all
published material on endemic infection of S. stercoralis acquired in Spain issued before
31st May 2018. We collected data from these articles and reported clinical and epidemio-
logical characteristics of patients. Our systematic review of the articles showed a clear geo-
graphical pattern; nearly 97% of the cases described had been acquired in the Valencia
province. Most of them (82.9%) were male, and most had current or past dedication to
agriculture. Our results showed that 70.3% had at least one condition or treatment that
could have made them more vulnerable to suffer a severe form of this helminthic disease.
Our data suggests that S. stercoralis infection probably remains underdiagnosed in Span-
ish population. Due to the scarce information available about endemic strongyloidiasis in
Spain until now, we believe that the present work will be relevant and the conclusions
derived from it might raise awareness about underdiagnosis. Transmission risk factors
described in the people diagnosed may be key for prevention and control strategies
implementation.
Introduction
Strongyloidiasis is a disease caused by soil-transmitted helminths, mainly by the species Stron-
gyloides stercoralis. This intestinal nematode infects an estimated 300 million people world-
wide, although this is probably underestimated. It is one of the most neglected of the neglected
tropical diseases (NTD) and is widely distributed [1–2]. Although it generally occurs in sub-
tropical and tropical countries, transmission is also possible in countries with temperate cli-
mates. Autochthonous cases have been described in Spain, possibly infected long time ago. It
remains uncertain whether S. stercoralis is currently endemic in Spain. Still, some authors con-
sider this country and some other southern European countries as endemic [3].
The life cycle of S. stercoralis is complex and follows multiple routes, including a complete
life cycle outside the human host. The most frequent mechanism of infection is percutaneous
entry of the filariform larvae. In healthy people, most of the cases are asymptomatic, although
it can cause intermittent symptoms that mainly affect the intestine, the lungs or the skin [4].
About criterion used to establish the diagnosis of strongyloidiasis is not homogenized
among the centers. The diagnostic laboratory criterion of strongyloidiasis is the observation of
larval stages. However, in chronic infection, larvae excretion may be low and fluctuating, and
microscopic observation is not sensitive enough and multiple stool specimens should be ana-
lyzed to increase the sensitivity of the method. The clinical criterion is a patient with epidemio-
logical antecedents and any of the associated clinical manifestations, especially if it is an
immunosuppressed patient.
These methods are laborious, time consuming, and in the case of fecal culture, requires well
trained technicians in order to differentiate S. stercoralis. Several immunological tests have
also been described (ELISA, IFAT and Western blot) with variable sensitivity and specificity
depending on the population tested among other factors [1].
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Alternative diagnostic methods, such as molecular biology techniques (mostly polymerase
chain reaction, PCR) have been implemented. However, PCR might not be suitable for screen-
ing purpose, whereas it might have a role as a confirmatory test, since it still misses a relevant
proportion of infected people [5].
Due to the subtle symptoms, low sensitivity of diagnostic techniques and the complex life-
cycle that can cause asymptomatic autoinfection for decades, the prevalence of S. stercoralis is
thought to be severely underestimated.
Typically risk factors for severe infection include immunosuppression, certain malignan-
cies, human T-cell lymphotropic virus type 1 infection, and alcoholism. Likewise, S. stercoralis
has been associated with agricultural or mining activities. In Germany, it was recognized as a
parasitic professional disease in miners [6]. S. stercoralis infection has also been linked to low
socioeconomic factors and infrastructure, indicating that it as a disease of disadvantage [7–8].
In recent years the number of diagnosed cases has been increasing in high income countries
due to the growing number of immigrants, travelers and refugees [9–10].
To provide information on this topic, a systematic review of the cases of endemic strongy-
loidiasis in Spain was carried out, as well as the description of the epidemiological characteris-
tics of these patients.
Methods
Aiming to assemble all scientific articles based on endemic strongyloidiasis diagnosed in
Spain, a systematic review was carried out. Relevant articles were retrieved from PubMed,
EMBASE, Scielo, ISI Web of Knowledge, and Cochrane Library databases using combinations
of the search terms adapted to each database. Additionally, Gray Literature in the form of com-
munications presented at national congresses was performed, as well as OpenGrey. As a sec-
ondary source, Google Scholar and free internet search was used for non-indexed articles. The
keywords were “Strongyloides stercoralis”, “soil-transmitted helminthiasis”, “endemic”, and
“Spain”. The following combinations of MeSH were used in PubMed: (Strongy� [MeSH] AND
Spain), ("Strongyloidiasis" [MeSH] AND Spain NOT "imported" NOT "immigrant"), and
("Strongyloidiasis" [MeSH] AND "endemic" AND "Spain").
The selection criteria were articles published in any language until May 31st 2018 that con-
tained the description of at least one human case of infection with S. stercoralis acquired in
Spain without a history of travel to endemic areas. No restrictions were applied based on the
study design or data collection. Human filter was applied. A manual search of the bibliographi-
cal references cited in the relevant articles was carried out.
All potential articles were analyzed by two researchers to assess compliance with the selec-
tion criteria. In situations of missed information, the corresponding author of the paper was
contacted to gather the information. If the author answered the required information to fulfill
the inclusion criteria, those articles were considered. If not, they were excluded because they
could not ensure the endemic acquisition.
The exclusion criteria included: animal studies, cases in which endemic infection could not
be assured, cases of foreigners from an endemic country for S. stercoralis, native people with
trips to endemic or probably endemic countries in the past (e.g. Italy, France or Portugal),
transplanted people in which this contagion route could not be excluded, and duplicated cases.
Based on these criteria the articles were reviewed in two stages. In the first stage, articles
were selected by titles and abstracts according to selection criteria. In the second stage, the full
text of the articles was analyzed. Finally, the articles that met the selection criteria were
included in the study.
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From each study the following data was extracted: the study period, year of publication and
number of endemic cases described. The following epidemiological data from patients
described in the studies was collected: age, gender, geographical origin, medical comorbidities
and concomitant treatments, occupation (or hobbies if relevant), other risk factors, year of
diagnosis, diagnostic technique used for diagnosis, presence of eosinophilia and clinical
symptoms.
Results
Thirty-six studies were included describing a total of 1083 patients with endemic strongyloidi-
asis in Spain (see Tables 1 and 2) [11–46]. The average age of the described cases was 68.35
years, ranging from 17 to 100 years old. Two hundred and eight of the 251 (82.9%) patients in
whom gender was reported were male, and most of them had current or past dedication to
agriculture. The province in whom most cases were described was Valencia, with 1049 people
diagnosed. Alicante had 13 and Murcia 5, eventually describing cases in provinces of coastal
oceanic climate with abundant rainfall most of the year and temperatures below 22˚C (Canta-
bria, Asturias, and Pontevedra). See Fig 1.
Regarding the number of diagnosed cases per year, a decreasing trend is observed since the
beginning of this decade. The year with higher number of diagnosed cases was 2003, with 82
patients. Since 2011, no more than 10 cases have been reported annually (Fig 2).
The technique that led to the diagnosis of strongyloidiasis was described in 743 patients
from twenty-six different articles. In some cases, different techniques were used for the same
diagnosis. In 692 patients (93.1%), the technique used for the definitive diagnosis of strongy-
loidiasis was the fresh stool examination, specific fecal culture, the Baermann test, the Ritchie
technique or the Harada Mori technique. In 39 patients (5.2%) the diagnosis was made by the
sputum or bronchoalveolar lavage examination. In 6 cases (0.8%) the diagnosis was made by
serological techniques and in another 6 cases (0.8%) the diagnosis was made by histopatholog-
ical analysis.
In 26 of the 37 patients individually described, comorbidities were reported. Out of those,
most frequent were diseases that associate the use of corticosteroids such as: chronic obstruc-
tive pulmonary disease (COPD), asthma, and inflammatory bowel diseases or immunosup-
pressive conditions due to advanced HIV infection (AIDS stage) or malignancies. In all
patients diagnosed with COPD, severity of airflow limitation (FEV1) was according to the
Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria at least moderate
GOLD 2 (50%� FEV1 < 80% predicted) if not severe: GOLD 3 (30%� FEV1 < 50%
predicted).
Overall, 70.3% of these patients had at least one comorbidity. In patients in whom blood
test results were reported, 41 out of the 50 (82%) exhibited eosinophilia. The median eosino-
phil count in patients with eosinophilia was 4,057 eosinophil/mm3; considering 24 individual
reported counts.
Discussion
Strongyloidiasis prevalence may be underestimated in many countries. With the data provided
by this review it is likely that underestimation could have been a reality for the last five decades
in Spain. The main cause would be the lack of clinical suspicion. But also the subtle symptoms,
the decades-long persistence of infection in untreated hosts and the absence of a diagnostic
test of choice with high sensitivity and specificity would ultimately contribute.
An important finding of our work is that almost 97% of all published infections occurred in
the province of Valencia. The fact that most cases diagnosed and published are in the province
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of Valencia, can respond to various reasons. Firstly, the area had the perfect combination of
temperature and humidity, population exposed to S. stercoralis for occupational reasons such
as rice farmers or irrigation ditch cleaners (activities that were characteristically carried out
barefoot) and hygiene factors of rural areas during the 1960s (lack of drinking water and toilets
in some homes). It is noteworthy that no cases of strongyloidiasis have been reported in other
areas with similar climatology and population equally dedicated to the cultivation of rice fields,
such as the Delta del Ebro in Tarragona province. We consider highly probable that there has
been transmission in other areas outside those described. Secondly, health care professionals
Table 1. Main characteristics of included articles.
Reference Study period Number of cases Year of publication
Duvignaud et al [11] 1 2016
Valerio et al [12] 01/2003–12/2012 2 2013
Ferna´ndez Rodrı´guez et al [13] 1 2012
Mayayo et al [14] 1 2005
Oltra Alcaraz et al [15] 261 2004
Martinez-Vazquez et al [16] 1 2003
Roma´n Sanchez et al [17] 31 2003
Roma´n Sanchez et al [18] 152 2001
Rodrı´guez Calabuig� et al [19] 10/1997–10/1999 15 2001
Cremades Romero et al [20] 1 1996
Rodrı´guez Calabuig� et al [21] 01/1994–06/1997 15 1998
Llagunes et al [22] 1 2010
Esteve-Martı´nez et al [23] 1 2013
Olmos et al [24] 1997 1 2004
Lo´pez Gaona et al [25] 1 2009
Escudero-Sanchez et al [26] 1 2017
Pacheco-Tenza et al [27] 01/1999–03/2016 4 2016
Esteban Ronda et al [28] 1 2016
Martinez-Perez et al [29] 2000–2015 1 2018
Igual Adell et al [30] 2007
Pretel Serrano et al [31] 1994–1999 3 2001
Ortiz Romero et al [32] 1 2007
Batista et al [33] 1 1992
Llenas Garcı´a et al [34] 01/1999–12/2017 9 2018
Tornero et al [35] 01/2002–12/2017 423 2018
Corbacho Loarte et al [36] 01/2008–12/2015 1 2017
Garcı´a Garcı´a et al [37] 2009–2010 2 2011
Igual et al [38] 2004–2005 112 2006
Lozano Polo et al [39] 1 2005
Cremades Romero et al [40] 04/1994–10/1995 32 1997
Sanchis-Bayarri et al [41] 1 1981
Tirado et a [42] 1 2002
Nevado et al [43] 1 1996
Sampedro et al [44] 1 1988
Lopez Gallardo et al [45] 1 1997
Toldos et al [46] 1 1995
� Data obtained through clarification of the main author
https://doi.org/10.1371/journal.pntd.0007230.t001
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Table 2. Clinical and epidemiological characteristics of patients with autochtonous strongyloidiasis in Spain.
Gender
and age
(in years)
City and
province of
residence
Occupation Comorbidity or
concomitant treatment
Other risk
factors
Year of
diagnosis
Diagnostic
techniques
Presence of
eosinophilia.
Eosinophils
count per
mm3.
Percentage of
eosinophils in
white blood
cell /percentage
of patients with
eosinophilia if
relevant
Clinical
symptoms
Ref.
W 17 La Safor,
Valencia
No data No data Walking
barefoot
2005 Fresh stool
examination and/or
fecal culture
Yes,
16,900
Abdominal pain,
diarrhea and
weight loss
[11]
W 61 No data No data Asthma and chronic
eosinophilic
pneumonia.
No data 2011 Serology Yes
1,480
20%
Chronic urticaria
and abdominal
pain
[13]
M 79 Zaragoza,
Arago´n
No data Mild malnutrition No data 2004 Bronchial aspirate
examination
No Abdominal pain [14]
261 M+W
patients,
21–100
years old
La Safor,
Valencia
124
agriculture
activities, 18
construction
activities
No data 33 irrigation
ditches
cleaners,
6 ditch baths
1995–
1999
Fresh stool
examination,
Baermann test and
fecal culture
No data No data [15]
M 25 Fornelos de
Montes,
Pontevedra
Logging
company
No data Occasional
agricultural
work and
bathing in
river
2002 Fresh stool
examination, and
examination after
concentration
(Ritchie)
Yes
22,000
Nonspecific skin
lesions and
abdominal pain
[16]
31 M
patients,
mean age
68.6 ± 8.0
Gandı´a,
Valencia
Farmers No data Work barefoot 2003 Fresh stool
examination and/or
fecal culture
No data No data [17]
120 M
and 32 W,
mean age
67
Gandı´a,
Valencia
Farmers and
farmer´s wives
44 COPD(no further
details), 38 heart disease,
7 solid neoplasia, and
1 HIV infection (no
further details
99 work
barefoot or
were spouses
of farmers, 13
drink non-
potable water
1990–
1997
Fresh stool
examination and
fecal culture
82% (n = 125)
had
eosinophilia
median count:
1,357+-811
severe cases
median count
694 +-309
41.65% (n = 63)
were
asymptomatic,
13% (n = 20) had
hyperinfection
syndrome or
disseminated
strongyloidiasis
[18]
15
patients,
mean age
66 ± 10
Oliva,
Valencia
68% farmers
(rice and
citric)
No data No data 1997–
1999
Fresh stool
examination and
fecal culture
100% (n = 15)
patients had
eosinophilia
(>500
eosinophils)
49% cough, 47%
pruritus, and 38%
dyspepsia
[19]
M 70 Ribera Baixa,
Valencia
Farmer COPD (FEV1 48%)
+ corticosteroids
No data 1995 Fresh stool
examination and/or
fecal culture
Yes
12,600
34%
Nausea, vomits,
weight loss and
abdominal pain
[20]
15 M+W,
mean age
65 (SD
11.5)
Oliva,
Valencia
Farmers No data 66.6% had
some risk
factor (work
barefoot, drink
non-potable
water)
1994–
1997
Fresh stool
examination and/or
fecal culture
No data 56.6% symptoms
(12% cough)
[21]
M 76 Valencia
Province
No data Crohn´s disease
+ corticosteroids
No data 2009 Bronchoalveolar
lavage
No Fever, arthralgia,
dyspnea
[22-
23]
(Continued)
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Table 2. (Continued)
Gender
and age
(in years)
City and
province of
residence
Occupation Comorbidity or
concomitant treatment
Other risk
factors
Year of
diagnosis
Diagnostic
techniques
Presence of
eosinophilia.
Eosinophils
count per
mm3.
Percentage of
eosinophils in
white blood
cell /percentage
of patients with
eosinophilia if
relevant
Clinical
symptoms
Ref.
M 57 Santander,
Cantabria
No data HIV infection
CD4 42/mm3
Rheumatoid arthritis
Corticosteroids
+ Immunosuppression
No data 2003 Postmortem
histopathological
examination
(trachea, lungs,
ileum, cecum and
pericolonic lymph
nodes)
No Anorexia,
dysphagia,
odynophagia,
night sweats,
weight loss,
diarrhea, and
acute respiratory
distress
[24]
W 82 Restiello-
Grado,
Asturias
No data No data Gardening
hobby
2008 Fresh stool
examination and/or
fecal culture
Yes
6,120
38%
Abdominal pain
and diarrhea
[25]
M 85 Born in
Extremadura,
living in
Madrid
Farmer No data No data 2017 Serology No data No data [26]
M 69 Orihuela,
Alicante
Farmer Lung carcinoma,
chemotherapy, inhaled
corticosteroids
No data 2007 Sputum
examination
Yes
600
Hemoptysis,
hyperinfection
syndrome
[27]
W 73 Redovan /
Vega Baja del
Segura.
Alicante
Farmer Diverticular disease No data 2015 Serology Yes
2,700
Abdominal pain
and diarrhea
[27]
M 80 Orihuela,
Alicante
Farmer Bladder tumor No data 2015 Fresh stool
examination and/or
fecal culture
Yes
700
Abdominal pain,
pruritus
[27]
M 72 Orihuela,
Alicante
Carrier COPD (no further
details)+ corticosteroids
Farmer’s work
in his free time
2015 Fecal culture,
serology,
histopathological
examination (colon)
biopsy)
Yes
2,400
Hyperinfection
syndrome
[27]
M 84 Chella,
Valencia�
Farmer Gastrectomy, asplenia,
malnutrition and
treatment with
corticosteroids
Walk barefoot 2016 Bronchial aspirate
examination
No Asthenia,
dysphagia, low-
grade fever,
anorexia, and
weight loss
[28]
M 40 Sta Cruz de
Tenerife,
Canarias
Construction
worker
Immunosuppression Walk barefoot
in mud
2006 Fresh stool
examination
Yes
No further data
Hyperinfection
syndrome
[29]
M 81 Vega del
Segura,
Murcia
Farmer COPD (FEV1 42%) Walk barefoot 1998 Fresh stool
examination
Yes
1500
21%
Abdominal pain
and pruritus
[31]
M 77 Vega del
Segura,
Murcia
Farmer COPD(FEV1 30%)
+ corticosteroids
Walk barefoot 1999 Fresh stool
examination
Yes
1,100
11%
Bronchospasm,
hemoptysis
[31]
(Continued)
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Table 2. (Continued)
Gender
and age
(in years)
City and
province of
residence
Occupation Comorbidity or
concomitant treatment
Other risk
factors
Year of
diagnosis
Diagnostic
techniques
Presence of
eosinophilia.
Eosinophils
count per
mm3.
Percentage of
eosinophils in
white blood
cell /percentage
of patients with
eosinophilia if
relevant
Clinical
symptoms
Ref.
M 82 Vega del
Segura.
Murcia
Farmer COPD (no further
details) + corticosteroids
Walk barefoot 1999 Fresh stool
examination
Yes
3,900
29%
Dyspnea,
wheezing,
abdominal pain,
meteorism, and
pruritus
[31]
M 85 Murcia No data COPD (FEV1 50%)
Corticosteroids for the
last month
No data 2008 Bronchial aspirate
examination
Yes
3,100
40.8%
Cough and
dyspnea
[32]
M 35 Sta Cruz de
Tenerife,
Canarias
No data HIV infection
CD4 36
No data 1992 Fresh stool
examination and/or
fecal culture
No Cough, fever,
vomits, and
diarrhea
[33]
8 M and 1
W, mean
age 79
Orihuela,
Alicante
6 farmers 2 neoplasia, 3 COPD
(no further details)
+ corticosteroids
No data 1999–
2017
Fresh stool
examination and/or
fecal culture, and
serology
88.9% (n = 8)
patients had
eosinophilia
median count
700
[34]
54
patients,
mean age
72.6 (SD
9)
La Safor.
Valencia
60% former
rice farmers
No data In 4 of them
bathing in
marshy waters
for
recreational
reasons was
assumed, or
parents had
worked on rice
fields
2009:17
cases
2010: 12
cases
2011: 10
cases
2012: 5
cases
2013: 1
case
2014: 4
cases
2015:2
cases
2016: 1
case
2017: 2
cases
Fresh stool
examination and/or
fecal culture
No data No data [35]
No data No data No data No data No data 2008–
2015
Harada Mori,
Baerman and/or
fecal culture
No data No data [36]
2 patients Valencia.
Valencia
No data No data No data 2009–
2010
Fecal culture and
Ritchie
concentration
method
No data No data [37]
112
patients
Gandı´a.
Valencia
No data No data No data 2004–
2005
Fresh stool
examination and/or
fecal culture
No data No data [38]
W 64 Santander,
Cantabria
No data Asthma
+ corticosteroids
No data 2005 Fresh stool
examination and/or
fecal culture
Yes
700
14%
Bilateral pleural
effusion and
respiratory failure
[39]
(Continued)
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in the area of Valencia probably had a greater awareness of the infection, with a higher suspi-
cion and therefore a higher number of diagnoses.
Although we concur that the estimated prevalence of S. stercoralis by one highly cited article
is not representative of the entire country, we disagree that Spain should not be considered an
endemic country [17]. However, autochthonous cases have been anecdotal in the last decade,
as indicated by Martinez-Perez [47].
The results of the individuals diagnosed showed an average age close to 70 years old.
Table 2. (Continued)
Gender
and age
(in years)
City and
province of
residence
Occupation Comorbidity or
concomitant treatment
Other risk
factors
Year of
diagnosis
Diagnostic
techniques
Presence of
eosinophilia.
Eosinophils
count per
mm3.
Percentage of
eosinophils in
white blood
cell /percentage
of patients with
eosinophilia if
relevant
Clinical
symptoms
Ref.
28 M + 4
W, mean
age 68
(SD 7)
La Safor,
Valencia
Farmers 62% of patients with
comorbidities: COPD,
asthma, alcoholism,
diabetes mellitus, and
neoplasia
Walk barefoot 1994–
1995
Fresh stool
examination and/or
fecal culture, and
bronchoalveolar
lavage
100% (n = 32)
had
eosinophilia
(>600)
65% had
respiratory,
digestive and/or
cutaneous
symptoms
[40]
M 71 Oliva.
Valencia
Farmer No data Walk barefoot 1981 Cytological
examination of an
abdominal
puncture, fresh stool
examination and/or
fecal culture
Yes
6,840
(38%)
Vomits and
abdominal pain
[41]
M 71 Vinaroz,
Castello´n
Farmer COPD (no further
details) + corticosteroids
Walk barefoot 2002 Bronchial aspirate
examination
No Acute respiratory
and renal failure,
rash, and
hemoptysis
[42]
W 63 Cantabria No data Asthma
+ corticosteroids
No data 1996 Fresh stool
examination
Yes
19%
Dyspnea, cough,
expectoration,
diarrhea, vomits
and pruritus
[43]
M 77 Oviedo,
Asturias
Coal Miner COPD (FEV1 30–50%)
+ inhaled
corticosteroids and
alcohol
No data 1988 Histopathological
examination
(duodenal biopsy)
No Weight loss and
gastrointestinal
symptoms
[44]
M 71 Almerı´a,
Almerı´a
No data Ulcerative colitis
+ corticoids
No data 1997 Bronchial aspirate,
stool and sputum
examination,
histopathological
examination (colon
biopsy)
No Abdominal pain,
diarrhea, fever,
dyspnea, cough,
and expectoration
[45]
M 58 Vega Media
del Segura,
Murcia
Farmer COPD (no further
details) + corticosteroids
No data 1994 Histopathological
examination
(duodenal biopsy),
fecal culture
Yes
12,496
44%
Abdominal pain,
diarrhea, vomits,
and weight loss
[46]
� Data obtained through clarification of the main author.
https://doi.org/10.1371/journal.pntd.0007230.t002
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Given the known characteristics of the disease the contagion probably took place decades
before the diagnosis, coinciding with the postwar period where hygienic conditions and infra-
structure were affected. On one hand, factors of unavoidable mention that directly affect the
transmission of this helminth are the improvement in hygienic conditions and the mechaniza-
tion of agricultural work. On the other hand, the increase of awareness by health care workers,
especially from the most affected communities, may have led to the diagnosis of new cases in
recent years.
An overall higher incidence rate in male gender is described, which is consistent with previ-
ous studies [15, 17, 21, 27]. This might be explained due to a gender biased; since some articles
focus on screening high risk population (farmers or smokers with COPD), traditionally associ-
ated with gender roles.
Regarding the diagnostic techniques used, there is great heterogeneity among the different
studies. The sensitivity of techniques based on microscopy is not good enough, particularly in
chronic infections. Serology is a useful tool but could overestimate the prevalence of the dis-
ease due to cross-reactivity with other nematode infections and its difficulty distinguishing
recent and past (and cured) infections. However, current serological tests are specific enough
and negativization or a decrease in the titers could be observed 6–12 month after treatment,
making this tool very useful [48].
Fig 1. Geographical distribution of autochthonous Strongyloides stercoralis infection in Spain. The map was
obtained from the open access website http://mapsvg.com/maps.
https://doi.org/10.1371/journal.pntd.0007230.g001
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There are some limitations that have to be mentioned. Inevitably there are cases of strongy-
loidiasis that have not been written for publication. In addition, ten articles had to be excluded
due to lack of information about travel history or did not comply with the minimum informa-
tion required. Therefore, it is highly probable that there were more than 1083 cases. Lastly,
given the characteristics of this review, it is possible that there are some duplicate cases in mul-
tiple description articles and described individually by another researcher.
In summary, there are still new diagnoses of autochthonous cases of strongyloidiasis in
Spain every year, especially as occupational hazard in a specific Spanish region. Although the
number of diagnoses is much lower than in the past decade, it is highly probable that the infec-
tion remains undiagnosed due to low clinical suspicion among Spanish population without
recent travel history. Epidemiological studies in at risk areas based on serological techniques
could give more information about the real situation of autochthonous cases of strongyloidia-
sis in Spain.
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